Mikusu India Private Ltd acquires 3,700 shares of Daikaffil Chemicals, raising its stake to 49.32%
The promoter bought 3,700 equity shares on June 12, 2026 via open market, lifting its holding to 29.59 million shares (49.32% of voting capital).
What Daikaffil Chemicals disclosed
On 15 June 2026, Daikaffil Chemicals India Ltd filed a Regulation 29(2) disclosure with BSE, reporting that its promoter, Mikusu India Private Limited, purchased 3,700 equity shares of the company on 12 June 2026. The shares were bought from the open market on the Bombay Stock Exchange (BSE). The filing confirms that the acquisition was made in compliance with the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 and that the transaction has been recorded on the exchange’s register.
Details of the acquisition
- Acquirer: Mikusu India Private Limited (promoter group)\
- Target: Daikaffil Chemicals India Ltd (Scrip Code: 530825)\
- Number of shares acquired: 3,700 equity shares\
- Mode of acquisition: Open‑market purchase on BSE\
- Date of acquisition: 12 June 2026 (disclosed on 13 June 2026)\
- Share price: Not disclosed in the filing\
- Post‑acquisition holding: 29,59,088 shares, representing 49.32% of the total voting capital\
- Pre‑acquisition holding: 29,55,388 shares, representing 49.26% of the total voting capital\
- Percentage of total share capital acquired: 0.06% (3,700 shares out of 60 lakh shares)\
- Equity share capital of Daikaffil Chemicals: Rs 6,00,00,000 (60 lakh shares of Rs 10 each) – unchanged by the transaction.
The filing also confirms that there were no encumbrances, pledges, or other securities attached to the shares acquired, and that no warrants, convertible securities, or voting rights other than shares were involved.
Regulatory compliance and filing specifics
The disclosure follows the format prescribed under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. The key elements required by the regulation – identity of the target and acquirer, mode of acquisition, number of shares, percentage of shareholding before and after the transaction, and the total share capital – are all provided in the filing.
- Acquirer’s status: The acquirer is listed as belonging to the promoter/promoter group of Daikaffil Chemicals.
- Exchange(s) involved: BSE Ltd (BSE) – the shares are listed only on BSE; no NSE listing is mentioned.
- DIN of the signatory: Raghuram K Shetty, Director of Mikusu India Private Limited (DIN 00038703).
- Date of filing: 15 June 2026 (timestamp 06:49:58 UTC).
No additional instruments such as preferential allotments, off‑market transfers, or rights issues were part of the transaction; it was a straightforward open‑market purchase.
Key facts at a glance
| Detail | Value |
|---|---|
| Target company | Daikaffil Chemicals India Ltd |
| Acquirer (promoter) | Mikusu India Private Limited |
| Scrip code / ticker | 530825 (BSE) |
| Shares acquired | 3,700 equity shares |
| Acquisition date | 12 June 2026 |
| Mode of acquisition | Open market (BSE) |
| Pre‑acquisition holding | 29,55,388 shares (49.26%) |
| Post‑acquisition holding | 29,59,088 shares (49.32%) |
| % of total share capital acquired | 0.06% |
| Total equity share capital | Rs 6,00,00,000 (60 lakh shares of Rs 10 each) |
| Filing date | 15 June 2026 |
| Source | BSE Regulation 29(2) disclosure (PDF) |
Why this matters for investors
The filing signals a continuation of promoter interest in Daikaffil Chemicals. By increasing its stake from 49.26% to 49.32%, the promoter moves marginally closer to the 50% threshold that often triggers additional disclosure or regulatory requirements under Indian takeover rules. However, the acquisition does not cross any material ownership change that would automatically compel a mandatory open offer under the SEBI takeover code, as the promoter’s holding remains below 50%.
For shareholders, the transaction does not dilute existing equity, because the shares were bought from the open market rather than issued anew. Consequently, there is no immediate impact on the company’s capital structure or earnings per share. The unchanged equity share capital of Rs 600 million confirms that the company’s balance sheet remains unaffected by this purchase.
Investors should note that the promoter’s willingness to buy additional shares may be interpreted as confidence in the company’s prospects, but the filing itself does not provide any forward‑looking statements, financial forecasts, or strategic rationale. The disclosure is purely a compliance requirement under SEBI regulations.
Conclusion
Mikusu India Private Limited, acting as a promoter of Daikaffil Chemicals India Ltd, purchased 3,700 equity shares on 12 June 2026 through the BSE open market. The transaction raised its shareholding to 49.32% of the total voting capital, a modest increase of 0.06% of the overall share pool. The filing satisfies SEBI’s Regulation 29(2) requirements and does not alter the company’s equity capital. The acquisition underscores ongoing promoter participation but does not, by itself, trigger any mandatory takeover offer or change in corporate control.
"The acquisition was made in compliance with SEBI’s Substantial Acquisition of Shares & Takeovers Regulations, 2011 and has been duly recorded on the exchange." – Disclosure filing, 13 June 2026
Frequently asked questions
Related stocks
Source filing: view original